96833-41-9

Basic information

• Product Name: 2-Chloro-4-MethoxypyriMidin-5-aMine
• Synonyms: 2-Chloro-4-MethoxypyriMidin-5-aMine;2-CHLORO-4-METHOXYPYRIMIDIN-5-AMIN;2-Chloro-4-methoxypyrimidin-5-ylamine;5-Amino-2-chloro-4-methoxypyrimidine;2-chloro-4-methoxypyrimidine-5-ylamine;2-chloro-4-methoxy-5-Aminopyrimidine
• CAS NO: 96833-41-9
• Molecular Formula: C5H6ClN3O
• Molecular Weight: 159.57364
• Mol File: 96833-41-9.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 349.6±22.0 °C(Predicted)
• Appearance: /
• Density: 1.398±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 1.36±0.29(Predicted)
• CAS DataBase Reference: 2-Chloro-4-MethoxypyriMidin-5-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-4-MethoxypyriMidin-5-aMine(96833-41-9)
• EPA Substance Registry System: 2-Chloro-4-MethoxypyriMidin-5-aMine(96833-41-9)

Safety Data

• Hazardous Substances Data: 96833-41-9(Hazardous Substances Data)

Usage

General Description

2-Chloro-4-MethoxypyriMidin-5-aMine, also known as CMMP or 2-chloro-4-methoxy-5-aminopyrimidine, is a chemical compound with the molecular formula C5H6ClN3O. It is a pyrimidine derivative and a building block used in the synthesis of pharmaceutical compounds. 2-Chloro-4-MethoxypyriMidin-5-aMine is an important intermediate for the production of various drugs, including antiviral and antifungal medications. It is also used in the development of agrochemicals and veterinary products. CMMP has potential applications in research and development related to the pharmaceutical and agricultural industries due to its versatile properties and functional groups.

Upstream product

• 5177-27-5 5-amino-2,4-dichloropyrimidine 
• 124-41-4 sodium methylate 
• 67-56-1 methanol 

Downstream Products

• 1608498-03-8 C₁₉H₂₄ClN₃O₂ 

Relevant articles and documents

N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS

A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

N-SUBSTITUTED 4-AMINOPHENOLS AND CORRESPONDING QUINONE IMINES

Compounds of formula I or formula II, wherein Q1Q3 and R1-R5 are as defined in the claims, exhibit CytC derived peroxidase inhibiting activity and are thus useful as CytC derived peroxidase inhibiting agents.

PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS

The present invention relates to the use of certain pyrrolopyridineamino derivatives (hereinafter referred to as "PPA derivatives"), particularly 1H-pyrrolo[3,2-c]pyridine-6- amino derivatives, to inhibit the spindle checkpoint function of Monospindle 1 (Mps1 – also known as TTK) kinases either directly or indirectly via interaction with the Mps kinase itself. In particular, the present invention relates to PPA derivatives for use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of the PPA derivatives, and pharmaceutical compositions comprising them. Formula (I)